McKesson Corporation (MCK)
NYSE: MCK · Real-Time Price · USD
826.51
+1.59 (0.19%)
Jan 6, 2026, 4:00 PM EST - Market closed
McKesson Employees
McKesson had 51,000 employees as of March 31, 2024. The number of employees did not change compared to the previous year.
Employees
51,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$7,590,078
Profits / Employee
$79,078
Market Cap
102.01B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 51,000 | 0 | - |
| Mar 31, 2023 | 51,000 | -24,000 | -32.00% |
| Mar 31, 2022 | 75,000 | -1,000 | -1.32% |
| Mar 31, 2021 | 76,000 | -4,000 | -5.00% |
| Mar 31, 2020 | 80,000 | 0 | - |
| Mar 31, 2019 | 80,000 | 2,000 | 2.56% |
| Mar 31, 2018 | 78,000 | 0 | - |
| Mar 31, 2017 | 78,000 | 10,000 | 14.71% |
| Mar 31, 2016 | 68,000 | -2,400 | -3.41% |
| Mar 31, 2015 | 70,400 | 27,600 | 64.49% |
| Mar 31, 2014 | 42,800 | -700 | -1.61% |
| Mar 31, 2013 | 43,500 | 5,800 | 15.38% |
| Mar 31, 2012 | 37,700 | 1,300 | 3.57% |
| Mar 31, 2011 | 36,400 | 3,900 | 12.00% |
| Mar 31, 2010 | 32,500 | 0 | - |
| Mar 31, 2009 | 32,500 | -400 | -1.22% |
| Mar 31, 2008 | 32,900 | 1,100 | 3.46% |
| Mar 31, 2007 | 31,800 | 5,400 | 20.45% |
| Mar 31, 2006 | 26,400 | 1,200 | 4.76% |
| Mar 31, 2005 | 25,200 | 600 | 2.44% |
| Mar 31, 2004 | 24,600 | 100 | 0.41% |
| Mar 31, 2003 | 24,500 | 500 | 2.08% |
| Mar 31, 2002 | 24,000 | 1,000 | 4.35% |
| Mar 31, 2001 | 23,000 | 1,900 | 9.00% |
| Mar 31, 2000 | 21,100 | -3,500 | -14.23% |
| Mar 31, 1999 | 24,600 | 10,900 | 79.56% |
| Mar 31, 1998 | 13,700 | 400 | 3.01% |
| Mar 31, 1997 | 13,300 | 2,000 | 17.70% |
| Mar 31, 1996 | 11,300 | -900 | -7.38% |
| Mar 31, 1995 | 12,200 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MCK News
- 15 days ago - McKesson Corporation: FY26 Earnings Visibility Underpins Buy Case - Seeking Alpha
- 15 days ago - Mckesson Corporation Announces Third Quarter Fiscal 2026 Earnings Release Date - Business Wire
- 17 days ago - Our Top 10 High-Growth Dividend Stocks - December 2025 - Seeking Alpha
- 4 weeks ago - McKesson Corporation (MCK) Presents at Evercore 8th Annual Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - McKesson's Advancing Community Oncology Report Charts a New Era of Innovation for Biopharma and Community Care - Business Wire
- 7 weeks ago - Our Top 10 High Growth Dividend Stocks - November 2025 - Seeking Alpha
- 2 months ago - McKesson Corporation (MCK) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 2 months ago - McKesson Corporation (MCK) Q2 2026 Earnings Call Transcript - Seeking Alpha